Facebook Twitter LinkedIn Google Plus RSS

Keller named head of commercial operations of Daiichi Sankyo Inc.

By

Global pharmaceutical company Daiichi Sankyo Inc. announced Friday that Ken Keller will join the company as president of its commercial operations in the United States, headquartered in Parsippany, starting May 1, 2014.

According to the announcement, Keller will be responsible for leading marketing, sales, medical affairs and supply chain operations for the company.

"We are very pleased to welcome Ken Keller into the Daiichi Sankyo family," Joji Nakayama, president and CEO, Daiichi Sankyo Co. Ltd., the parent company of the Daiichi Sankyo Group, said in a prepared statement. "Ken brings with him more than 25 years of pharmaceutical experience, with career highlights including building a $3 billion business unit as well as leading commercialization for four of the world's top selling biologic medicines. His broad experience and proven success will be a tremendous asset to Daiichi Sankyo."

Most recently, Keller was the executive vice president and chief operating officer at Spectrum Pharmaceuticals. Prior to that, he spent 21 years at Amgen, the announcement said.

ALSO ON NJBIZ:

An inside look: Here's life in the new Panasonic building

An open, casual and comfortable workspace is the way of the future

Furniture: For comfort, culture and convenience, it's the key to office interiors

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!